the effect of tiropramide hydrochloride -- a new spasmolytic drug with calmodulin-independent activity -- in correcting alterations of intestinal transit , has been investigated in 40 ibs patients ( 20 with accelerated and 20 with delayed transit time ) .
C0021853
intestinal
C0022104
ibs